| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 20.00 |
Jordan COVID-19 Emergency Response
Abstract*
The purpose of the COVID-19 Emergency Response Project in Jordan is to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and strengthen the national health system for public health preparedness. This project consists of three components. Component one aims to prevent and limit the spread of COVID-19 (Coronavirus) in Jordan. Component two will provide support for the International Coordination and Project Management Unit (ICPMU)... Show More
Development Objective
The Project Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and
strengthen the national health system for public health preparedness.
Key Details
Project Details
P173972
Closed
Takahiro Hasumi
Hashemite Kingdom of Jordan
April 19, 2020
(as of board presentation)
April 28, 2020
May 13, 2020
US$ 20.00 million
Ministry of Health
2020
US$ 20.00 million
N/A
April 25, 2024
January 31, 2024
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 20.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 20.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 20.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 28, 2020 | IBRD-91080 | Loan Commitment | 20,000,000.00 |
| May 13, 2020 | IBRD-91080 | Fee Charges | 50,000.00 |
| May 15, 2024 | IBRD-91080 | Int Charges | 746,146.25 |
| Mar 11, 2024 | IBRD-92860 | Loan Disb | 6,630,448.50 |
| Apr 15, 2024 | IBRD-92860 | Int Charges | 12,317.20 |
| Mar 14, 2024 | IBRD-91080 | Loan Disb | -163.62 |
| Apr 15, 2024 | IBRD-92860 | Int Charges | 14,590.07 |
| Apr 15, 2024 | IBRD-92860 | Int Charges | 1,233,488.40 |
| May 31, 2024 | IBRD-92860 | Loan Cancel | 6,294,627.50 |
| May 31, 2024 | IBRD-91080 | Loan Cancel | 163.62 |
| Oct 15, 2023 | IBRD-92860 | Int Charges | 14,836.98 |
| Oct 15, 2023 | IBRD-92860 | Int Charges | 19,147.64 |
| Oct 15, 2023 | IBRD-92860 | Int Charges | 1,065,328.40 |
| Nov 15, 2023 | IBRD-91080 | Int Charges | 710,444.44 |
| Jun 2, 2023 | IBRD-92860 | Loan Disb | 8,963,924.00 |
| May 15, 2023 | IBRD-91080 | Int Charges | 671,711.10 |
| Apr 15, 2023 | IBRD-92860 | Int Charges | 28,750.66 |
| Apr 15, 2023 | IBRD-92860 | Int Charges | 17,990.96 |
| Apr 15, 2023 | IBRD-92860 | Int Charges | 701,545.50 |
| Nov 15, 2022 | IBRD-91080 | Int Charges | 363,911.10 |
| Oct 15, 2022 | IBRD-92860 | Int Charges | 393,908.78 |
| Jan 19, 2022 | IBRD-92860 | Loan Disb | 27,986,000.00 |
| Apr 15, 2022 | IBRD-92860 | Int Charges | 29.37 |
| Apr 15, 2022 | IBRD-92860 | Int Charges | 63,438.14 |
| Nov 15, 2021 | IBRD-91080 | Int Charges | 59.39 |
| Nov 15, 2021 | IBRD-91080 | Int Charges | 182,348.33 |
| Mar 7, 2022 | IBRD-91080 | Loan Disb | 68,802.26 |
| May 15, 2022 | IBRD-91080 | Int Charges | 52.78 |
| May 15, 2022 | IBRD-91080 | Int Charges | 183,624.95 |
| Oct 6, 2021 | IBRD-92860 | Loan Disb | 125,000.00 |
| Oct 6, 2021 | IBRD-92860 | Fee Charges | 125,000.00 |
| May 15, 2021 | IBRD-91080 | Int Charges | 124,235.04 |
| Nov 15, 2020 | IBRD-91080 | Int Charges | 6.66 |
| Nov 15, 2020 | IBRD-91080 | Int Charges | 53,474.25 |
| Feb 8, 2021 | IBRD-91080 | Loan Disb | 14,000,000.00 |
| Jun 26, 2020 | IBRD-91080 | Loan Disb | 5,881,197.50 |
| May 13, 2020 | IBRD-91080 | Loan Disb | 50,000.00 |
| Jun 16, 2021 | IBRD-92860 | Loan Commitment | 50,000,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2024-05-01 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-05-01 |
| Procurement | Satisfactory | 2024-05-01 |
| Project Management | Satisfactory | 2024-05-01 |
| Financial Management | Moderately Satisfactory | 2024-05-01 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-05-01 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of hospitals that comply with COVID-19 case management per WHO protocol Value 0.00 32.00 32.00 Date April 7, 2020 March 6, 2024 June 15, 2022 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan. Value 0.00 46.00 40.00 Date April 1, 2021 March 6, 2024 January 31, 2024 Comment Share of female healthcare workers fully vaccinated Value 32.00 99.00 65.00 Date April 11, 2021 March 6, 2024 January 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of newly renovated health facilities fully equipped with medical equipment and commodities for COVID-19 Value 0.00 4.00 2.00 Date April 7, 2020 March 6, 2024 June 15, 2022 Comment M&E system established to monitor COVID-19 preparedness and response plan Value No Yes Yes Date April 7, 2020 March 6, 2024 June 15, 2022 Comment Percentage of grievances received through the project’s Grievance Redress Mechanism (GRM) addressed within 14 days which is publicly communicated. Value 0.00 80.00 100.00 Date April 1, 2021 March 6, 2024 January 31, 2024 Comment